JPMorgan Chase & Co’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Buy |
24,880
+921
| +4% | +$4.15K | ﹤0.01% | 4744 |
|
|
2025
Q1 | $111K | Sell |
23,959
-135
| -0.6% | -$626 | ﹤0.01% | 4687 |
|
|
2024
Q4 | $167K | Buy |
24,094
+5,551
| +30% | +$38.5K | ﹤0.01% | 4601 |
|
|
2024
Q3 | $98.3K | Buy |
18,543
+5,125
| +38% | +$27.2K | ﹤0.01% | 4732 |
|
|
2024
Q2 | $50.2K | Buy |
13,418
+597
| +5% | +$2.23K | ﹤0.01% | 4903 |
|
|
2024
Q1 | $90.4K | Sell |
12,821
-9,215
| -42% | -$65K | ﹤0.01% | 4769 |
|
|
2023
Q4 | $125K | Sell |
22,036
-7,418
| -25% | -$41.9K | ﹤0.01% | 4675 |
|
|
2023
Q3 | $141K | Buy |
29,454
+4,026
| +16% | +$19.3K | ﹤0.01% | 4422 |
|
|
2023
Q2 | $174K | Buy |
25,428
+1,028
| +4% | +$7.04K | ﹤0.01% | 4349 |
|
|
2023
Q1 | $190K | Buy |
24,400
+6,064
| +33% | +$47.2K | ﹤0.01% | 4351 |
|
|
2022
Q4 | $140K | Sell |
18,336
-707
| -4% | -$5.4K | ﹤0.01% | 4359 |
|
|
2022
Q3 | $156K | Buy |
19,043
+1,335
| +8% | +$10.9K | ﹤0.01% | 4264 |
|
|
2022
Q2 | $171K | Sell |
17,708
-4,804
| -21% | -$46.4K | ﹤0.01% | 4392 |
|
|
2022
Q1 | $316K | Buy |
22,512
+10,838
| +93% | +$152K | ﹤0.01% | 4223 |
|
|
2021
Q4 | $239K | Buy |
11,674
+7,242
| +163% | +$148K | ﹤0.01% | 4441 |
|
|
2021
Q3 | $99K | Buy |
+4,432
| New | +$99K | ﹤0.01% | 4720 |
|